热门资讯> 正文

Thomus报告第一季度业绩

2026-05-11 20:54

安帝君斯(AGEN) 0

Agenus press release (AGEN): Q1 Cash and cash equivalents totaled $35.0 million as of March 31, 2026, compared with $3.0 million as of December 31, 2025.
The company also expects to collect outstanding receivables under regulatory-authorized early access programs during the second quarter of 2026.

More on Agenus

Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript
Agenus Q4 2025 Earnings Preview
GSK wins FDA label expansion for RSV vaccine, Arexvy
Seeking Alpha’s Quant Rating on Agenus
Historical earnings data for Agenus

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。